The neurology resident at Massachusetts General Brigham talked about assessing the safety of cancer treatments in patients with multiple sclerosis using checkpoint inhibitors. [WATCH TIME: 6 minutes]
Prashanth Rajarajan, MD, PhD
Advertisement
Neurology resident at Massachusetts General Brigham.
Articles by Prashanth Rajarajan, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Issues Complete Response Letter for Spinocerebellar Ataxia Agent Troriluzole
2
Dental Caries and Periodontal Disease Increase Ischemic Stroke Risk, Study Shows
3
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
4
FDA Feedback Provides Clarity for Phase 3 Trial of Neflamapimod in Dementia With Lewy Bodies
5
